发明名称 GENE EXPRESSION MARKER FOR PREDICTING RESPONSE TO CHEMOTHERAPEUTIC AGENT
摘要 PROBLEM TO BE SOLVED: To provide sets of genes the expression of which is important in the prognosis of cancer, in particular, gene expression information useful for predicting whether cancer patients are likely to have a beneficial treatment response to chemotherapy.SOLUTION: A method for determining the likelihood of a beneficial response of a human patient with breast cancer to an anthracycline-based chemotherapy, comprises: determining a normalized expression level of an RNA transcript, or its expression product, of DICER1 in a breast cancer sample obtained from the patient; and predicting the likelihood of a beneficial response of the patient to the anthracycline-based chemotherapy, using the DICER1 normalized expression level, wherein the DICER1 normalized expression level is negatively correlated with the likelihood of a beneficial response of the patient to the anthracycline-based chemotherapy.
申请公布号 JP2013176388(A) 申请公布日期 2013.09.09
申请号 JP20130103045 申请日期 2013.05.15
申请人 GENOMIC HEALTH INC;FONDAZIONE IRCCS IST NAZIONAL DEI TUMORI 发明人 BAKER JOFFRE B;SHAK STEVEN;GIANNI LUCA
分类号 C12Q1/68;C12N15/09 主分类号 C12Q1/68
代理机构 代理人
主权项
地址